IBP Statistics

Total Valuation

Indo-Bangla Pharmaceuticals has a market cap or net worth of BDT 1.05 billion. The enterprise value is 1.07 billion.

Market Cap	1.05B
Enterprise Value	1.07B

Important Dates

The last earnings date was Monday, October 28, 2024.

Earnings Date	Oct 28, 2024
Ex-Dividend Date	Dec 4, 2024

Share Statistics

Indo-Bangla Pharmaceuticals has 116.21 million shares outstanding. The number of shares has decreased by -5.98% in one year.

Current Share Class	n/a
Shares Outstanding	116.21M
Shares Change (YoY)	-5.98%
Shares Change (QoQ)	+3.61%
Owned by Insiders (%)	27.08%
Owned by Institutions (%)	13.56%
Float	84.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.74
PB Ratio	0.65
P/TBV Ratio	n/a
P/FCF Ratio	13.96
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 30.22, with an EV/FCF ratio of 14.29.

EV / Earnings	-59.19
EV / Sales	5.06
EV / EBITDA	30.22
EV / EBIT	n/a
EV / FCF	14.29

Financial Position

The company has a current ratio of 4.67, with a Debt / Equity ratio of 0.02.

Current Ratio	4.67
Quick Ratio	2.07
Debt / Equity	0.02
Debt / EBITDA	0.99
Debt / FCF	0.47
Interest Coverage	-0.57

Financial Efficiency

Return on equity (ROE) is -1.12% and return on invested capital (ROIC) is -0.09%.

Return on Equity (ROE)	-1.12%
Return on Assets (ROA)	-0.08%
Return on Capital (ROIC)	-0.09%
Revenue Per Employee	1.09M
Profits Per Employee	-93,217
Employee Count	194
Asset Turnover	0.11
Inventory Turnover	0.94

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.06% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-47.06%
50-Day Moving Average	9.95
200-Day Moving Average	14.14
Relative Strength Index (RSI)	51.44
Average Volume (20 Days)	156,070

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Indo-Bangla Pharmaceuticals had revenue of BDT 211.61 million and -18.08 million in losses. Loss per share was -0.16.

Revenue	211.61M
Gross Profit	29.58M
Operating Income	-2.36M
Pretax Income	-6.22M
Net Income	-18.08M
EBITDA	35.42M
EBIT	-2.36M
Loss Per Share	-0.16

Full Income Statement

Balance Sheet

The company has 10.48 million in cash and 35.01 million in debt, giving a net cash position of -24.53 million or -0.21 per share.

Cash & Cash Equivalents	10.48M
Total Debt	35.01M
Net Cash	-24.53M
Net Cash Per Share	-0.21
Equity (Book Value)	1.61B
Book Value Per Share	13.83
Working Capital	417.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 88.41 million and capital expenditures -13.48 million, giving a free cash flow of 74.93 million.

Operating Cash Flow	88.41M
Capital Expenditures	-13.48M
Free Cash Flow	74.93M
FCF Per Share	0.64

Full Cash Flow Statement

Margins

Gross margin is 13.98%, with operating and profit margins of -1.12% and -8.55%.

Gross Margin	13.98%
Operating Margin	-1.12%
Pretax Margin	-2.94%
Profit Margin	-8.55%
EBITDA Margin	16.74%
EBIT Margin	-1.12%
FCF Margin	35.41%

Dividends & Yields

Indo-Bangla Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	5.98%
Shareholder Yield	5.98%
Earnings Yield	-1.80%
FCF Yield	7.16%

Dividend Details

Stock Splits

The last stock split was on June 14, 2022. It was a forward split with a ratio of 1.03.

Last Split Date	Jun 14, 2022
Split Type	Forward
Split Ratio	1.03

Scores

Indo-Bangla Pharmaceuticals has an Altman Z-Score of 5.53.

Altman Z-Score	5.53
Piotroski F-Score	n/a